Secondary Logo

Journal Logo

June 1999 - Volume 22 - Issue 3
pp: 215-322

Mature Results From a Phase II Trial of Accelerated Induction Chemoradiotherapy and Surgery for Poor Prognosis Stage III Non-Small-Cell Lung Cancer

Adelstein, David J.; Rice, Thomas W.; Rybicki, Lisa A.; More

American Journal of Clinical Oncology. 22(3):237-242, June 1999.

Adjuvant (Cisplatin, Etoposide, and 5-Fluorouracil) Chemotherapy After Curative Resection of Gastric Adenocarcinomas Involving the Esophagogastric Junction

Ryoo, Baek-Yeol; Kang, Yoon-Koo; Im, Young-Hyuck; More

American Journal of Clinical Oncology. 22(3):253-257, June 1999.

Phase III Controlled Evaluation of Glutamine for Decreasing Stomatitis in Patients Receiving Fluorouracil (5-FU)-Based Chemotherapy

Okuno, Scott H.; Woodhouse, Charles O.; Loprinzi, Charles L.; More

American Journal of Clinical Oncology. 22(3):258-261, June 1999.

Epirubicin, Folinic Acid, Fluorouracil, and Etoposide in the Treatment of Advanced Gastric Cancer: Phase II Study of the Southern Italy Oncology Group (GOIM)

Colucci, Giuseppe; Giuliani, Francesco; Gebbia, Vittorio; More

American Journal of Clinical Oncology. 22(3):262-266, June 1999.

Phase I-II Trial of Intensification of the MAID Regimen With Support of Lenograstim (rHuG-CSF) in Patients With Advanced Soft-Tissue Sarcoma (STS)

Chevreau, Christine; Bui, Binh Nguyen; Chevallier, Bernard; More

American Journal of Clinical Oncology. 22(3):267-272, June 1999.

First-Line Treatment With Mitoxantrone, Methotrexate, Vincristine, and Carboplatine (MIMOC) Plus Cyclical Hormonotherapy With Tamoxifen and Megestrol Acetate in Advanced Breast Cancer

Kakolyris, S.; Samonis, G.; Koukourakis, M.; More

American Journal of Clinical Oncology. 22(3):273-277, June 1999.



Show: